50% off Premium Yearly

NYSE:MMM
This summary was created by AI, based on 2 opinions in the last 12 months.
3M Co. is currently at a pivotal moment as it prepares to report its quarterly results. The newly appointed CEO is optimistic about the company's future, suggesting that a turnaround is on the horizon. However, some analysts urge caution, stating that while the immediate uncertainties have been resolved, the company now appears to be a lower-growth multi-industrial. They recommend taking profits and exploring investments in more robust alternatives within the industrial sector, such as Honeywell International Inc. or segments of other well-performing firms. As 3M navigates this transitional phase, investors are left weighing the potential benefits of the CEO's direction against the broader structural challenges of the business landscape.
Had a little bit of difficulty. Seem to have been 1 step forward and 2 steps back over the last several years. This has happened to a lot of the industrial conglomerates because the global economy has not been steady. Over the last couple of quarters they have got it together a little bit and most of their divisions are moving in concert and doing fairly well. Doesn’t feel it is overpriced at 14X earnings. Decent dividend.
J.P. Morgan did a list of 15 stocks whose free cash flow yield was fairly substantial and have had great resilience in down markets and have outperformed markets on the upside. This was one of them. This is an international conglomerate including healthcare. Thought it was a bit on the expensive side but based on the report by J.P. Morgan, he is going to have a look at this one.
Feels it is cheap right now but is probably likely to stay cheap for the next little while. Global growth which is not overly robust, doesn’t favour the space that this company is in. He likes their broad geographic exposure. 40%-50% of their revenues are earned outside of the US with quite a bit in more rapidly growing emerging markets. You’ll have to be patient with it. 2.5% dividend.